Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2519-2524

  Lindgren, Ola ^a   Carr, Richard D ^b   Deacon, Carolyn F ^c   Holst, Jens J ^c   Pacini, Giovanni ^d   Mari, Andrea ^d   Ahreń, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; LIPID EMULSION; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; LEAN BODY WEIGHT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; TRIACYLGLYCEROL BLOOD LEVEL; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; EMULSIONS; FATTY ACIDS, NONESTERIFIED; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; PHOSPHOLIPIDS; SOYBEAN OIL; TRIGLYCERIDES; YOUNG ADULT;

EID: 79961244091     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0266     Document Type: Article

References (31)

1. Elrick H, Stimmler L, Hlad Jr CJ, Arai Y 1964 Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 24:1076-1082
2. Holst JJ, Vilsbøll T, Deacon CF 2009 The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297:127-136
3. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W 1986 Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492-498 (Pubitemid 16035703)
4. Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahrén B 2008 Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J Physiol Endocrinol Metab 295:E779-E784
5. Manco M, Bertuzzi A, Salinari S, Scarfone A, Calvani M, Greco AV, Mingrone G 2004 The ingestion of saturated fatty acid triacylglycerols acutely affects insulin secretion and insulin sensitivity inhuman subjects. Br J Nutr 92:895-903 (Pubitemid 40028850)
6. Boden G, Carnell LH 2003 Nutritional effects of fat on carbohydrate metabolism. Best Pract Res Clin Endocrinol Metab 17:399-410
7. Driscoll DF 2006 Lipid injectable emulsions. Nutr Clin Pract 21:381-386
8. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539 (Pubitemid 24096293)
9. Deacon CF, Nauck MA, Meier J, Hücking K, Holst JJ 2000 Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 85:3575-3581
10. Van Cauter E, Mestrez F, Sturis J, Polonsky KS 1992 Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
11. Vilsbøll T, Krarup T, Madsbad S, Holst JJ 2003 Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 114:115-121 (Pubitemid 36773875)
12. Salehi M, Aulinger B, Prigeon RL, D'Alessio DA 2010 Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. Diabetes 59:1330-1307
13. Salehi M, Vahl TP, D'Alessio DA 2008 Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. J Clin Endocrinol Metab 93:4909-4916
14. Tseng CC, Zhang XY, Wolfe MM 1999 Effect of GIP and GLP-1 antagonists on insulin release in the rat. Am J Physiol Endocrinol Metab 276:E1049-E1054 (Pubitemid 29323420)
15. Hansotia T, Drucker DJ 2005 GIP and GLP-1 as incretin hormones: lessons from single and double incretin knockout mice. Regul Pept 128:125-134 (Pubitemid 40380913)
16. Feinle C, Chapman IM, Wishart J, Horowitz M 2002 Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men. Peptides 23:1491-1495 (Pubitemid 35223018)
17. Feltrin KL, Little TJ, Meyer JH, Horowitz M, Smout AJ, Wishart J, Pilichiewicz AN, Rades T, Chapman IM, Feinle-Bisset C 2004 Effects of intraduodenal fatty acid, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 287:R524-R533 (Pubitemid 39095925)
18. Thomsen C, Rasmussen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, Hermansen K 1999 Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 69:1135-1143 (Pubitemid 29252045)
19. Ellrichmann M, Kapelle M, Ritter PR, Holst JJ, Herzig KH, Schmidt WE, Schmitz F, Meier JJ 2008 Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations. J Clin Endocrinol Metab 93:3995-3998
20. O'Donovan D, Horowitz M, Russo A, Feinle-Bisset C, Murolo N, Gentilcore D, Wishart JM, Morris HA, Jones KL 2004 Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes. Diabetologia 47:2208-2214 (Pubitemid 40174694)
21. Pilichiewicz A, O'Donovan D, Feinle C, Lei Y, Wishart JM, Bryant L, Meyer JH, Horowitz M, Jones KL 2003 Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes. J Clin Endocrinol Metab 88:3829-3834 (Pubitemid 37034535)
22. Shah U, Kowalski TJ 2010 GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. Vitam Horm 84:415-448
23. Edfalk S, Steneberg P, Edlund H 2008 GPR40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of insulin secretion. Diabetes 57:2280-2287
24. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G 2005 Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-94 (Pubitemid 40215843)
25. Parker HE, Reimann F, Gribble FM 2010 Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med 12:e1
26. Kjems LL, Holst JJ, Vølund A, Madsbad S 2003 The influence of GLP-1 on glucose-stimulated insulin secretion: effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380-386 (Pubitemid 36173193)
27. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M 2006 Fatty acid signaling in the β-cell and insulin secretion. Diabetes 55(Suppl 2):S16-S23 (Pubitemid 44927028)
28. Morgan NG, Dhayal S 2009 G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic β-cell. Biochem Pharmacol 78:1419-1427
29. Ahrén B 2000 Autonomic regulation of islet hormone secretion. Implications for health and disease. Diabetologia 43:393-410 (Pubitemid 30237947)
30. Langhans W, Leitner C, Arnold M 2011 Dietary fat sensing via fatty acid oxidation in enterocytes: possible role in the control of eating. Am J Physiol Regul Integr Comp Physiol 300:R554-R565
31. Tentolouris N, Tsigos C, Perea D, Koukou E, Kyriaki D, Kitsou E, Daskas S, Daifotis Z, Makrilakis K, Raptis SA, Katsilambros N Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism 52:1426-1432